1 정은자, "항암 화학요법 환자의 피로 관련 요인" 한국호스피스완화의료학회 7 (7): 179-188, 2004
2 권영은, "항암 화학요법 암 환자의 피로와 삶의 질과의 관계 연구" 11 : 820-830, 1999
3 양영희, "위암환자의 항암 화학요법에 따른 피로와 삶의 질 변화 양상" 한국간호과학회 32 (32): 482-491, 2002
4 양영희, "방사선 치료를 받는 암환자의 피로, 삶의 질 및 신체 증상의 변화 양상" 한국간호과학회 33 (33): 562-569, 2003
5 심병용, "말기암 환자에서의 하지부종" 한국호스피스완화의료학회 8 (8): 152-155, 2005
6 Piper BF, "The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer" 25 : 677-684, 1998
7 Mendoza TR, "The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory" 85 : 1186-1196, 1999
8 Schwartz AL, "The Schwartz Cancer Fatigue Scale: testing reliability and validity" 25 : 711-717, 1998
9 Chang VT, "Symptom and quality of life survey of medical oncology patients at a Veterans Affairs Medical Center" 88 : 1175-1183, 2000
10 Kaye J, "Sleep patterns in patients with cancer and patients with cardiac disease" 114 : 107-113, 1983
1 정은자, "항암 화학요법 환자의 피로 관련 요인" 한국호스피스완화의료학회 7 (7): 179-188, 2004
2 권영은, "항암 화학요법 암 환자의 피로와 삶의 질과의 관계 연구" 11 : 820-830, 1999
3 양영희, "위암환자의 항암 화학요법에 따른 피로와 삶의 질 변화 양상" 한국간호과학회 32 (32): 482-491, 2002
4 양영희, "방사선 치료를 받는 암환자의 피로, 삶의 질 및 신체 증상의 변화 양상" 한국간호과학회 33 (33): 562-569, 2003
5 심병용, "말기암 환자에서의 하지부종" 한국호스피스완화의료학회 8 (8): 152-155, 2005
6 Piper BF, "The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer" 25 : 677-684, 1998
7 Mendoza TR, "The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory" 85 : 1186-1196, 1999
8 Schwartz AL, "The Schwartz Cancer Fatigue Scale: testing reliability and validity" 25 : 711-717, 1998
9 Chang VT, "Symptom and quality of life survey of medical oncology patients at a Veterans Affairs Medical Center" 88 : 1175-1183, 2000
10 Kaye J, "Sleep patterns in patients with cancer and patients with cardiac disease" 114 : 107-113, 1983
11 Porock D, "Nutritional, functional, and emotional characteristics related to fatigue in patients during and after biochemotherapy" 32 : 661-667, 2005
12 Mock V, "NCCN practice guidelines for cancer-related fatigue" 14 : 151-161, 2000
13 Hwang SS, "Multidimensional independent predictors of cancer-related fatigue" 26 : 604-614, 2003
14 Hann DM, "Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory" 9 : 847-854, 2000
15 Curt GA, "Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition" 5 : 353-360, 2000
16 Visser MR, "How response shift may affect the measurement of change in fatigue" 20 : 12-18, 2000
17 Visser MR, "Fatigue, depression and quality of life in cancer patients: how are they related?" 6 : 101-108, 1998
18 Jacobsen PB, "Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates" 18 : 233-242, 1999
19 Pater JL, "Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group Studies Employing the EORTC QLQ-C30" 5 : 410-413, 1997
20 Stone P, "Fatigue in patients with cancer" 34 : 1670-1676, 1998
21 Nail LM, "Fatigue in patients with cancer" 29 : 537-, 2002
22 Cella D, "Fatigue in cancer patients compared with fatigue in the general United States population" 94 : 528-538, 2002
23 Okuyama T, "Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale" 8 : 215-222, 2000
24 Mast ME, "Correlates of fatigue in survivors of breast cancer" 21 : 136-142, 1998
25 Maughan TS, "Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial" 359 : 1555-1563, 2002
26 National Cancer Institute, "Common terminology criteria for adverse events v3.0"
27 Malone M, "Assessment of the impact of cancer on work, recreation, home, management and sleep using a general health status measure" 87 : 386-389, 1994
28 Harper P, "Anaemia of cancer: impact on patient fatigue and long-term outcome" 69 (69): 2-7, 2005